Journey Medical director granted 10,000 RSUs

Pearce Michael Cooper reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Pearce Michael Cooper reported acquisition or exercise transactions in this Form 4 filing.

Journey Medical Corp director Michael Cooper received a grant of 10,000 restricted stock units (RSUs). The award, granted on June 25, 2026 under the company’s 2015 Stock Plan, will vest in full as 10,000 shares on June 25, 2027. After this grant, Cooper directly holds 67,173 shares of Journey Medical common stock, including RSUs that vest over various time periods.

Insider Trade Summary

Grant/Award: 10,000 shares

Grant/Award 1 txn

Insider Pearce Michael Cooper

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.0001 par value	10,000	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.0001 par value — 67,173 shares (Direct)

Footnotes (2)

1. F1. On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027.
2. F2. Includes restricted stock units, which vest over various time periods.

Key Figures

RSU grant size: 10,000 units Grant price per share: $0.0000 per share Vesting amount and date: 10,000 shares on June 25, 2027 +1 more

4 metrics

RSU grant size 10,000 units Restricted stock units granted June 25, 2026

Grant price per share $0.0000 per share RSU grant to director Michael Cooper

Vesting amount and date 10,000 shares on June 25, 2027 Vesting schedule for the RSU award

Shares owned after transaction 67,173 shares Total direct holdings following the grant

Key Terms

restricted stock units, 2015 Stock Plan, vest

3 terms

restricted stock units financial

"the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2015 Stock Plan financial

"granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended"

vest financial

"which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Journey Medical (DERM) report in Michael Cooper’s latest Form 4?

Journey Medical reported that director Michael Cooper received 10,000 restricted stock units as a grant. The award was made under the company’s 2015 Stock Plan and is structured as equity compensation rather than a cash transaction or open-market share purchase.

How many Journey Medical shares did Michael Cooper receive in this Form 4 filing?

Michael Cooper was granted 10,000 restricted stock units, each representing one share of common stock upon vesting. These RSUs are part of his equity compensation package and are scheduled to convert into shares if the vesting conditions and timeline are satisfied.

When do Michael Cooper’s 10,000 Journey Medical RSUs vest?

The 10,000 restricted stock units granted to Michael Cooper vest in full on June 25, 2027. On that date, subject to plan conditions, the RSUs convert into 10,000 shares of Journey Medical common stock, increasing his directly owned share count accordingly.

What is Michael Cooper’s total Journey Medical share ownership after this grant?

After the RSU grant, Michael Cooper directly holds 67,173 Journey Medical shares, including restricted stock units. This total reflects both currently issued shares and RSUs that vest over different periods, as described in the filing’s ownership and footnote disclosures.

Was there a purchase price for Michael Cooper’s 10,000 Journey Medical RSUs?

The Form 4 lists a transaction price of $0.0000 per share for the 10,000 RSUs, indicating a compensation grant. RSUs are typically awarded at no cash cost to the director, with value realized when shares are delivered at vesting under the stock plan.

Under which plan were Michael Cooper’s Journey Medical RSUs granted?

The 10,000 restricted stock units were granted under Journey Medical’s 2015 Stock Plan, as amended. This equity incentive plan governs how awards like RSUs are issued, their vesting schedules, and the terms under which they convert into common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:17 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pearce Michael Cooper

(Last) (First) (Middle)

C/O JOURNEY MEDICAL CORPORATION

9237 E VIA DE VENTURA BLVD., SUITE 105

(Street)

SCOTTSDALE ARIZONA 85258

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Journey Medical Corp [ DERM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value	06/25/2026		A		10,000(1)	A	$0	67,173(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027.

2. Includes restricted stock units, which vest over various time periods.

	/s/ Ramsey Alloush, attorney-in-fact	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)